Sonoma Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 08/14/2024 | 195,157 | $41,412 | 100.00% | 1.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 86,644 | $18,385 | 142.16% | 0.56% |
| JANE STREET GROUP, LLC | 08/15/2024 | 45,295 | $9,611 | 100.00% | 0.29% |
| STATE STREET CORP | 08/14/2024 | 24,315 | $5,160 | 0.00% | 0.16% |
| HRT FINANCIAL LP | 08/12/2024 | 21,519 | $4,000 | 100.00% | 0.14% |
| XTX TOPCO LTD | 08/12/2024 | 19,834 | $4,209 | 20.48% | 0.13% |
| TWO SIGMA SECURITIES, LLC | 08/14/2024 | 15,325 | $3,252 | 13.75% | 0.10% |
| UBS GROUP AG | 08/14/2024 | 11,917 | $2,527 | 11,469.90% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 8,268 | $1,753 | -30.99% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 3,400 | $722 | 100.00% | 0.02% |
| BLACKROCK INC. | 08/13/2024 | 2,266 | $481 | 0.00% | 0.01% |
| US BANCORP \DE\ | 08/07/2024 | 500 | $106 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 200 | $42 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 172 | $36 | 290.91% | 0.00% |
| MORGAN STANLEY | 10/17/2024 | 86 | $18 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 07/24/2024 | 65 | $21 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 33 | $7 | -72.95% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sonoma Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 5 institutional investors and hedge funds held shares of Sonoma Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BANK OF AMERICA CORP /DE/: 0
MORGAN STANLEY: 0
CITADEL ADVISORS LLC: 0
BlackRock Inc.: 2,266
LADENBURG THALMANN FINANCIAL SERVICES INC.: 166
2.79% of Sonoma Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2,432 shares in the last 24 months. This purchase volume represents approximately $6,542 in transactions.